UnitedHealthcare and Humana are ending Medicare Advantage plans for nearly 1 million people
Reported by Fortune · fortune.com ·
When payers end a plan, they either want to lose those customers altogether or get those customers to switch to a different, typically pared down and more profitable plan, Brooks Conway, a principal at Oliver Wyman actuarial consulting, told Healthcare Brew.
Story context
What to watch: Monitor Healthcare & Pharma for follow-through — insufficient signal for directional thesis.
Latest session change: $HUM +2.99%
How this was labelled
Fortune published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $HUM. The preview above is the publisher's own wording.
When it landed
It landed while New York was open, so the session move beside it may include the reaction.
Where the price is
$HUM last traded at $427.38, +2.99% on the session. That is 6.4% below its 52-week high of $456.50 and 162% above its low of $163.11 — within a tenth of its 52-week high. The year's range spans 180% from low to high: a very wide band for one year, the kind of volatility where large swings are routine. These are latest-session quotes, not live prices.
How much is being written
Wook has stored 6 stories about $HUM in the last 30 days, 1 of them this week. At the 30-day pace you would expect about 1 a week, so this week is quieter than usual. Across those stories the wording ran 33% bullish, 50% neutral and 17% bearish; this one reads neutral, so it sits with the majority of the run. This is the only one from Fortune; the rest came from other outlets. 12 of them are listed beside this one.
The backdrop
Healthcare stories tend to turn on approvals, trial data and pricing: an FDA decision or a trial readout can move a single drugmaker sharply, while drug-pricing policy moves the whole group. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it reads.
What is already on the calendar
$HUM earnings in 17 days. These were scheduled before this story and are not caused by it.
Where to look next
The $HUM page has the full chart, the filings and the valuation model behind these figures. Comparing how two or three outlets frame the same story is the quickest way to separate the facts from the angle. Wook AI, above, can pull live figures and do the math — how far $HUM is from its high, or how this week's coverage compares — on request.
What this page is not saying
The tone and severity labels come from a fixed word list — no editor, no AI — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.